48,830
edits
(→Gross) |
(→IHC) |
||
Line 109: | Line 109: | ||
==IHC== | ==IHC== | ||
Primary versus metastatic: | Primary versus metastatic: | ||
*TTF-1 +ve. | |||
*CK7 +ve. | *CK7 +ve. | ||
*CK20 -ve. | *CK20 -ve. | ||
Panel for adenocarcinoma versus SCC: | |||
*TTF-1 +ve. | *TTF-1 +ve. | ||
*Napsin A +ve. | |||
*p40 -ve.<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref> | *p40 -ve.<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref> | ||
*CK5/6 -ve. | |||
Others: | |||
*p63 -ve -- occasionally +ve. | *p63 -ve -- occasionally +ve. | ||
edits